Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vi Capsular Polysaccharide Typhoid Vaccine

Known as: Vi, ViCPS, typhoid, ViCPs 
A live attenuated bacteria injectable vaccine used to prevent typhoid, which is caused by Salmonella typhi.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Summary Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20 million infections and 200 000… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
We have demonstrated that magnetic carbon nanocomposite fabrics prepared by microwave assisted heating are advanced adsorbents in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
ABSTRACT Typhoid fever remains a serious problem in developing countries. Current vaccines are licensed for individuals who are 5… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Chromium (VI) is a widely used industrial chemical, extensively used in paints, metal finishes, steel including stainless steel… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
To the Editor: The limitations of the three licensed typhoid vaccines that precluded their use in children younger than five… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Typhoid fever is common in developing countries. The licensed typhoid vaccines confer only about 70 percent immunity… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Objective: To estimate the efficacy and toxicity of typhoid fever vaccines. Design: Meta-analysis of randomised efficacy trials… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The protective efficacy and immunogenicity of Vi capsular polysaccharide vaccine against typhoid fever was measured 3 years after… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
To improve its immunogenicity for children and adults and to make it suitable for routine immunization of infants against typhoid… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
We conducted a pilot study followed by a large clinical trial in Nepal of the use of the capsular polysaccharide of Salmonella… Expand
Is this relevant?